Home › Funds › Prosight Management, LP › PRCT

Prosight Management, LP position in PRCT

PROCEPT BIOROBOTICS CORP · Health Care

Prosight Management, LP reported holding 268,269 shares of PRCT (PROCEPT BIOROBOTICS CORP) in its Q2 2026 13F filing — a position valued at US$6.1M, representing 1.04% of its reported portfolio and ranking #21 among its reported holdings. Prosight Management, LP has disclosed PRCT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)268.27K sh
Reported value held$6.06M
Portfolio Weight1.04%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Prosight Management, LP's PRCT position evolved

Prosight Management, LP first disclosed a stake in PRCT in Q3 2025 at 76,991 shares (US$2.7M). The position peaked in Q1 2026 at 1,945,000 shares, worth US$48.6M. Across 4 filings, Prosight Management, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 268,269 shares valued at US$6.1M — a reduction of -1,676,731 shares quarter over quarter.. Notable position changes include a 1692% increase in Q4 2025 (shares fell 21% over the following quarter), a 41% increase in Q1 2026 (shares fell 10% over the following quarter), a 86% trim in Q2 2026 (shares fell 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 76.99K $2.75M New
Q4 2025 1.38M $43.41M Add
Q1 2026 1.95M $48.64M Add
Q2 2026 268.27K $6.06M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRCT and 13F data

PRCT (PROCEPT BIOROBOTICS CORP) is a Health Care company. 18 other funds we track also report a position in PRCT — the largest reported positions include Soleus Capital Management, L.P. (US$22.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRCT

All PRCT fund holders →

FAQ

How long has Prosight Management, LP held PRCT?

Prosight Management, LP has disclosed PRCT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Prosight Management, LP's current position in PRCT?

As of Q2 2026, Prosight Management, LP holds 268.27K shares of PRCT (PROCEPT BIOROBOTICS CORP), valued at $6.06M, representing 1.04% of its reported portfolio and ranking #21.

Has Prosight Management, LP been buying or selling PRCT?

In the latest 13F filing (Q2 2026), Prosight Management, LP reduced its position in PRCT. The position peaked in Q1 2026 at 1.95M shares.

Which other funds hold PRCT?

Other major institutional holders of PRCT include Soleus Capital Management, L.P., among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.